期刊
ACTA PHARMACOLOGICA SINICA
卷 27, 期 4, 页码 387-394出版社
ACTA PHARMACOLOGICA SINICA
DOI: 10.1111/j.1745-7254.2006.00315.x
关键词
SRC-3/AIB1; oncogene; mouse model; cancer; signal transduction
资金
- NCI NIH HHS [CA58204] Funding Source: Medline
- NIDDK NIH HHS [U01DK63 424] Funding Source: Medline
Steroid receptor coactivator-3 (SRC-3, also known as NCoA3, AIB1, p/CIP, RAC3, ACTR, and TRAM1), localized on a frequently amplified region, 20q12, has been associated with multiple cancers, including breast, gastric and prostate cancers. Although SRC-3 has been implicated as an oncogene, compelling evidence has only recently emerged implicating it as a causal factor in the genesis of human cancers. Here, we summarize recent evidence that indicates aberrant SRC-3 expression is important in hormone-sensitive and -insensitive human cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据